期刊文献+

肝癌的分子分型与肝癌的诊治 被引量:7

下载PDF
导出
作者 夏锋
出处 《实用临床医药杂志》 CAS 2010年第7期1-2,共2页 Journal of Clinical Medicine in Practice
基金 国家传染病科技重大专项资助项目(2008ZX10002-26)
  • 相关文献

参考文献12

  • 1Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma [ J ]. Hepatology, 2005, 42 : 1208.
  • 2Llovet JM, Burroughs A, Bmix J. Hepatocellular carcinoma [J]. Lancet, 2003, 362: 1907.
  • 3Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55: 74.
  • 4El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis [ J ]. Gastroenterology, 2007, 132: 2557.
  • 5Sherman M. Hepatocellular carcinomaz epidemiology, risk factors, and screening[J]. Semin Liver Dis, 2005, 25: 143.
  • 6Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence acmss five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24: 2137.
  • 7Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors[J ]. Gastroenterology, 2004, 127(Suppl 1): S35.
  • 8Llovet JM, Ricci S, Mazzaferm V, et al. Sorafenib in advanced hepatocellular earcinorna[J]. N Engl J Med, 2008, 359 : 378.
  • 9Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia - Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double- blind, placeboeontrolled trial [ J ]. Lancet Oncol, 2009, 10: 25.
  • 10Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis, from genes to envimnment[J ]. Nat Rev Cancer, 2006, 6 : 674.

同被引文献95

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部